Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree :)
As long as NWBO management are not convicted felons I am pretty sure Merck won’t give a foek and just buys DCVAX. 2 days later after the BO no one will remember the name NWBO retired LP and LG. Not even you lol
Crash is not saying anything spectacular. Warren Buffett already said this about management:
Warren Buffett on judging management: ‘See how they treat themselves versus how they treat the shareholders’
https://www.cnbc.com/2018/05/08/warren-buffett-heres-how-to-judge-management.html
so let that sink in when thinking about NWBO management hahahahahahahahahaha
lol OMG
Im selling as well PM, just that Im waiting for the SP to hit 2$ again, which it will after MHRA approval.
Why on earth would a (small) biotech aiming to get a high-end new cancer drug approved, want to have a Medical Doc with experience in treating patients as their CTO/Chief Medical Officer? It's the same as saying the CTO of Boeing should be a pilot, no the CTO of Boeing should be a core airplane engineer. Take for example Christopher Missling, Ph.D. CEO of another promising biotech startup. He never treated any Alzheimer's/Parkinson's or any other patient for that matter.
What you need as CTO better yet CEO and what both Missling and Bosch have in common are specialists in Pharmaceutical scientists or biochemistry, not medicine. MD and specialists in Medicine are the pilots of the plane they have some knowledge of how the drugs are being developed but you dont want them to assemble/engineer the plane or drug.
Bosvch has an impressive career in cancer drug development he really is the right man for the right position. You really dont want an oncologist in his position. For the medical trial itself, one can rely on outsides MDs such as LL and Ashkin.
Having said that I have said here repeatedly that putting two greedy nonpracticing lawyers in the front seat of a high-end cancer biotech is the worse you can think do if you want to have the drug on the market within 12 years.
I have said repeatedly make Bosch CEO fire Les and have LP take care of the finances+deals.
Can you refer me or quote Advent advertising to get customers in? I have not seen any advertisement of Advent not even in LinkedIn and I have been searching really hard. And a general text in their website how wonderful they are is not advertising. Advent employees 50 staff of which NOT ONE in sales or marketing isn’t that odd. I have not seen one customer mentioned by Advent. It would also be odd for a customer to assigning Advent at this point without Advent being certified.
One post you laugh at specials not having any revenue the other they have 5 million. Ok 5 million isn’t nearly enough to pay salaries of 50 highly qualified staff ex other expensive overhead. If DCVAX would fail NWBO SP would get sub 5 cents in that case NWBO will not be able to fund Advent. Advent would need from here hence on at least 2 years to get by without NWBO or without producing DCVAX.
You asked why that’s why
Good Questions I would like answered as well. Btw dr Marnix Bosch is NWBOs chief tech officer.
Its beyond me why you pretend NWBO is the only listed company worldwide that has no fiduciary obligation to inform its shareholders, management can do the hell what they want, steps going forward do not need to be communicated and any shareholder voting no for an increase of authorized shares or demand answers should just sell. Not even listed companies on the Pyongyang stock exchange are allowed this level of authoritarian and undemocratic regime.
I cannot for the life of me imagine the market has concluded from the creation of the Cs they wil be dumping 250 million in common on the market. There will be no serious buyer for that number without any reported goals achieved. I really believe the chunk of the Cs are for a professional investor with deep pockets at higher SP. Question is what are they planning todo with the proceeds of the selling of the Cs. I do not believe it’s for Direct as asserted by Les.
But boy ooh boy what incredibly bad timing to create 250 million common in Cs. Theses Cs are now hovering above an almost empty market. They are beyond stupid or don’t give a F or both
100% agree
those saying NWBO will market DCVAXL alone think that LP and LG are 35 years :)
seriously I agree that thtas what the JA is for among others
ooh come on if NWBO does not deliver the goods there will be nor more NWBO. No one wants to buy the Cs nor will the ASM approve any increase of A/S if the goods are not delivered. No achieved goals no increase of SP, no increase of A/S no shares to sell no money to pay for new CDMOs. And Im talking the next max 6-9 months your next 6 years are absurd. And management knows this.
This is starting to get ridiculous. I don't mind if you are critical of management but please stay realistic.
People listen there will be NO REVENUE at Advent Uk specials as long as no journal article has appeared. And even after the JA has proven for MDs they should send their patients to get DCVAX L treatment, 75% of patients cant afford DCVAX L without approval and reimbursement agreements. That's just the reality of life.
This whole idea of high revenue at specials was always a fairy tale at this stage
I know you are not sensitive to mathematical debunking your incorrect calculations which have been provided to you over and over. Therefore try this to understand. If your claim that DCVAX L is not working were true than:
A. we would not have a x3 better OS than Stupp
B. NWBO management would go to jail for not disclosing that material event
C. Dr Liau and Dr Ashkan among others would lose their licenses for claiming endpoints have been met while anonymous poster exwannebe claims it has not met endpoints,
Its so silly what you assert and statistically big nonsense.
EU/UK and US endpoints do not differ
EU/UK/
The first secondary objective is to compare overall survival (OS) between patients randomized to placebo who received DCVax-L treatment following disease recurrence and control patients from comparable, contemporaneous clinical trials, in patients with recurrent GBM.
US
1. The first secondary objective is to compare overall survival (OS) between patients randomized to placebo who received DCVax-L treatment following disease recurrence, and control patients from comparable, contemporaneous clinical trials, in recurrent GBM.
[ Time Frame: Until death ]
exact the same
It has been stated more than once by the company and LL that the SAP is the same with every RA
If the trial had failed based on ex his false claims NWBO would should have disclosed that info ions ago. Unless ofcourse the company is selling Cs now fully aware about this material event.
I 100% agree with you that LPs self-interest and three-way entanglement is incredibly unethical.
However, we were mentioning the silver lining which is would LP screw over Advent Bio employees/staff by providing them worthless shares/warrants after they have reached their goal posts (getting to the MIA certificate)?I don't think so. Apparently, LP holds the opinion that after Advent is certified NWBO shares will increase in value which will ONLY happen if the DCVAXL L is approved by the MHRA.
well the silver lining is why would LP pay Advent staff/management with worthless NWBO shares/options/warrants if her main purpose is to sell Advent and dump NWBO? Advent staff/management would be extremely unhappy if they would see NWBO go belly up and under and Advent got sold off.
Normally start-up employees are rewarded by an employee stock option pool of the company itself. I would be extremely worried if Advent staff/management demanded to be rewarded in Advent shares and specifically not in NWBO shares. So to keep Adven staff/management happy NWBP SP must increase in value.
flipper you mean this?
https://www.adventbio.uk/post/innovate-uk-s-global-business-innovation-programme-to-canada
Jun 23
Innovate UK's Global Business Innovation Programme to Canada
We were delighted to be part of Innovate UK's Global Business Innovation Programme to Canada focusing on Biomanufacturing of Advanced Therapies.
Canada punches above its weight as a home to world-leading universities, hospitals, institutes and labs; and the cohort will get to experience this in Vancouver and Toronto, two of Canada's life sciences hubs. They’ll explore a growing sector that’s benefiting from the recent implementation of a life science and biomanufacturing strategy; and meet with potential collaborators, from both Canada and the UK.
Alessandra De Riva our Head of PD and R&D is very much looking forward to represent Advent Bioservices in July.
If they start selling C's in order to fund Advent Canada prior to MHRA approval then you can be assured You just have been NWBO scammed.
If the Cs are to finance Advent Canada and they have not filed MAA before the end of September then it's clear NWBO management is in it to finance CDMOs via Cancer stories and does not give a hood about DCVAX and shareholders and all longs have been swindled. It would be one of the biggest biotech scams of the last 20 years.
lol ooh good lord I can see ex jumping up and down now
as long as we dont get a PR about NWBO filed a MAA, you can be assured they have not filed one
well Im over the moon happy with $2 so I will take that right now and instantly given my average. I think at OTC we can reach 4$ max, of course, an uplisting would be a dream but PM realistically I really think you can scratch that off your list before EOY tbh.
If there are serious problems such for example all scientific journals refusing to publish the JA not even JTM, NWBO is not in the legal position to officially PR TLD because they now have come to the conclusion that endpoints have not been met, its impossible / no use to submit a request for approval in the UK, MIA will not be granted you know details like details. If those problems have occurred then these are material events that NWBO had to disclose and for which NWBO would be deemed liable if they would still keep selling their C's to retailers.
There is hope PM there really is, hang in there
September 27, 2014
yayayayayayayay shorts Wolfe pack naked shorts fabricated shorts Big Pharma coming after NWBO big money thugs engineering the price drop Adam Feuerstein complot theory the world is against NWBO Linda Powers is the new messiah fight against bears shorts Wolfe pack naked short fabricated shorts Big Pharma coming after NWBO big money thugs engineering the price drop Adam Feuerstein complot theory the world is against NWBO Linda Powers is the new messiah fight against bearsshort Wolfe pack naked short fabricated shorts Big Pharma coming after NWBO big money thugs engineering the price drop Adam Feuerstein complot theory the world is against NWBO Linda Powers is the new messiah fight against bearsshort Wolfe pack naked short fabricated shorts Big Pharma coming after NWBO big money thugs engineering the price drop Adam Feuerstein complot theory the world is against NWBO Linda Powers is the new messiah fight against bears
Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack Wolfe pack
Wolfe pack conspiring against NWBO Wolfe pack conspiring against NWBOWolfe pack conspiring against NWBOWolfe pack conspiring against NWBOWolfe pack conspiring against NWBOWolfe pack conspiring against NWBOWolfe pack conspiring against NWBOWolfe pack conspiring against NWBOWolfe pack conspiring against NWBOWolfe pack conspiring against NWBOWolfe pack conspiring against NWBOWolfe pack conspiring against NWBO
nope wont happen. We are at support and oversold. SP will bounce back to 68
longs selling shares are not short they are from an investment point going from a long to a neutral position.
Shorts are traders selling shares without owning these shares with the aim to buy back after the SP dropped thus making a profit. When these shorts buy to neutralize their short position does not make them longs.
NWBO SP dropping is because of longs exiting their long position which does not make them shorts.
I agree with you Vato. Like I have said before if a divine intervention would give me a choice: you will have to wait 1 year and then NWBO will have approval 100% in the UK I would seal the deal and sleep like a baby. The problem is that NWBO has made so many promises which were not kept and have screwed up so many timelines that there is no way to know if in one year, two years, or three years from now they will have RA approval. Any biotech would have already submitted a request for approval but not NWBO. NWBO MC is where its today because it does not like the uncertainty surrounding NWBO which management created.
If no news this year then why are they holding off the ASM? Makes no sense
If everything is screwed up beyond recognition then still they will have to organize and ASM. If not they will be legally accountable.
I still believe they are waiting for JA+TLD officially/MIA and submitting of MA which after they will announce ASM. Im counting on ASM in Nov. I also believe that if these 3 are in the SP will get back to 2$ which by the way I will sell and never look back.
aah ok thanks
If we knew with 75% certainty its another 9 months until MHRA approval it would be fine to wait but the problem is we dont know that. With NWBO its always years longer not months. And then there is the financial situation.
Where is the JA and why have they not filed MAA as of today? SP loves this kind of uncertainty not. SP will suffer until these two lost items have been found.
What are ordering? Mexican taco? :)